HUMA short interest
Humacyte Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 29,399,293 |
|---|---|
| Change vs prior report | -2,408,273 (-7.6%) |
| Change over six months | -30.4% |
| Days to cover | 7.31 (sector: 3.78) |
| Average daily volume | 4,024,163 |
| Rank in Healthcare | #226 of 922 by days to cover |
HUMA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 29,399,293 | -7.6% | 7.31 | 4,024,163 |
| 2026-09-15 | 31,807,566 | +6.7% | 7.25 | 4,387,750 |
| 2026-08-31 | 29,813,381 | -6.7% | 3.40 | 8,761,921 |
| 2026-08-14 | 31,939,257 | +1.4% | 3.36 | 9,500,655 |
| 2026-07-31 | 31,488,080 | -2.5% | 6.92 | 4,552,596 |
| 2026-07-15 | 32,283,805 | +2.2% | 3.34 | 9,658,029 |
| 2026-06-30 | 31,597,133 | -13.9% | 1.25 | 25,184,498 |
| 2026-06-15 | 36,706,340 | -8.6% | 4.10 | 8,946,847 |
| 2026-05-29 | 40,140,620 | -2.5% | 6.14 | 6,537,068 |
| 2026-05-15 | 41,159,014 | -7.9% | 5.19 | 7,933,504 |
| 2026-04-30 | 44,703,015 | -0.3% | 10.01 | 4,464,779 |
| 2026-04-15 | 44,844,793 | +6.2% | 9.40 | 4,770,787 |
| 2026-03-31 | 42,223,438 | +3.8% | 3.03 | 13,920,612 |
| 2026-03-13 | 40,676,377 | +6.6% | 10.36 | 3,927,526 |
| 2026-02-27 | 38,162,880 | -2.6% | 8.88 | 4,297,365 |
| 2026-02-13 | 39,193,932 | +0.9% | 5.22 | 7,507,477 |
| 2026-01-30 | 38,837,697 | +4.5% | 8.05 | 4,823,532 |
| 2026-01-15 | 37,152,671 | +2.2% | 7.58 | 4,903,532 |
| 2025-12-31 | 36,355,101 | +2.7% | 6.47 | 5,620,744 |
| 2025-12-15 | 35,398,643 | +2.1% | 9.26 | 3,823,799 |
| 2025-11-28 | 34,652,802 | +3.7% | 7.31 | 4,742,543 |
| 2025-11-14 | 33,414,650 | +3.6% | 6.29 | 5,311,260 |
| 2025-10-31 | 32,241,263 | +18.4% | 7.83 | 4,117,825 |
| 2025-10-15 | 27,220,587 | -5.5% | 2.63 | 10,340,766 |
| 2025-09-30 | 28,794,874 | -16.2% | 7.44 | 3,869,340 |
import finzdata as yf
yf.Ticker("HUMA").short_interest # every report since 2017
yf.Client().short_interest(["HUMA"], start="2018-01-01")Healthcare short interest · HUMA price history · Who owns HUMA · All short interest